Lei Miao
Molecular Biology · with Anderson · 2019
A researcher in the Science corpus: 1 paper; trusts 7 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 49 citations into it
- Genetics — 7 citations into it
Whom Lei Miao trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Lei Miao's perspective
Ordered by how strongly the researchers Lei Miao trusts endorse each paper. Same corpus, a different order for every researcher.
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction (Nature Biotechnology)
- mRNA-based therapeutics — developing a new class of drugs (Nature reviews. Drug discovery)
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis (New England Journal of Medicine)
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice (Nature Biotechnology)
- Nonviral delivery of self-amplifying RNA vaccines (Proceedings of the National Academy of Sciences of the United States of America)
- A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. (Molecular Therapy)
- Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling (Nature Biotechnology)
- Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape (Nature Biotechnology)
- Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. (Biomaterials)
- Principles of nanoparticle design for overcoming biological barriers to drug delivery (Nature Biotechnology)
Their papers
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. (2019) — 924 citations